CLINICAL TRIAL CONTRACT INTELLIGENCE

Clinical trial contracts that close in days, not months.

The average CTA negotiation takes 90+ days and every day of delay costs $1.3M. TrialPact is AI-native contract intelligence built for emerging biotech sponsors — not Big Pharma.

90+ days avg. CTA negotiation
63% of trial starts, no legal ops team
$1.3M daily cost of trial delay
Join Waitlist → See the Simulation ↓

No implementation fees · No dedicated legal ops team needed · Built for Phase 1–3

CTA_draft_v3.docx AI Reviewing
Mutual indemnification missing
Publication rights — accepted

The $1.3M/day problem no one talks about.

Half of all clinical trial delays trace back to contracting. CTA negotiation averages 90+ days — and emerging biotechs absorb this delay without a dedicated legal ops team.

90+ days, every time

The average clinical trial agreement takes 90+ days to negotiate. Every contract restart, missed redline, or back-and-forth email thread adds weeks of delay — and millions in direct cost.

50% of trial delays — contracting

63% have no legal ops team

The majority of Phase 1–3 trial starts come from emerging biotechs that don't have dedicated legal operations. Every contract falls on clinical or finance teams without institutional knowledge or precedents.

63% of trial starts — no legal ops

$1.3M lost per day

Every day of trial delay is estimated to cost $1.3M in direct R&D burn, deferred revenue, and competitive disadvantage. Contracting delays don't feel expensive — until you do the math.

$1.3M/day — documented industry cost
LIVE SIMULATION

See TrialPact review a real CTA.

Interact with the AI review engine and template library. This is the actual product experience.

CTA_MassGeneral_v2.docx Phase 2 Oncology
4.2 INDEMNIFICATION Sponsor shall indemnify and hold harmless the Institution, its trustees, officers, employees and agents (collectively 'Institution Parties') from and against any and all claims, damages, losses, costs and expenses (including reasonable attorneys' fees) arising out of or resulting from the Sponsor's negligence or willful misconduct in connection with this Agreement or the Study.
5.1 SUBJECT INJURY In the event a Study subject suffers an injury as a direct result of receiving the Investigational Product according to the Study protocol, Sponsor agrees to provide or arrange for medical treatment of such injury at no cost to the subject, to the extent such injury is not covered by the subject's health insurance or other third-party payor.
6.3 PUBLICATION RIGHTS Institution shall have the right to publish the results of the Study. Sponsor shall have thirty (30) days to review any proposed publication for confidential or proprietary information prior to submission. Sponsor may not unreasonably withhold consent to publication.
Clause analysis: 3 of 6 categories reviewed
AI Analysis
2 items need attention · 1 approved · 3 clauses remaining

Every capability a lean clinical ops team needs.

No 6-month implementation. No dedicated legal ops team required. Purpose-built for emerging biotech sponsors.

Core — All plans Growth — Scale plans Scale — Enterprise

AI Redlining with Pharma Context

Not generic AI. TrialPact understands that 'promptly' vs 'immediately' has legal significance in a site agreement. Flags deviations from your pre-approved positions and suggests fallback language drawn from 847+ pharma-specific precedent CTAs.

Core · All plans

Negotiation Memory Engine

Every accepted and rejected position is stored. The next time you contract with the same institution, TrialPact preloads prior accepted positions. Your institutional knowledge compounds — it doesn't disappear when a team member leaves.

Growth · Scale plans

Budget ↔ Contract Linkage

Milestone payment schedules tied directly to contract language. Flags when contracted payment terms conflict with your study budget. Alerts before a billing window closes — not after you've already missed it.

Growth · Scale plans

Fair Market Value Benchmarking

Every investigator fee benchmarked against FMV data in real time. Flags payments outside safe harbor ranges before signature. What currently requires a compliance audit to surface, TrialPact flags before the ink dries.

Core · All plans

Country-Specific Clause Intelligence

Multi-jurisdictional trials covered. Mandatory local law clauses surfaced automatically when a non-US site is added. No more negotiating terms that local statute already mandates.

Scale · Enterprise

Pre-Signature Compliance Check

Before any CTA is signed: protocol version match verified, indemnification checked against FDA guidance, financial interest disclosure requirements confirmed per 21 CFR 54. What a $500/hour regulatory attorney does — automated at signature time.

Core · All plans

From draft to signed in three steps.

1

Upload or draft

Start from a TrialPact template or upload your existing draft in .docx or PDF. AI extracts clause structure and maps to the standard 6-category framework in under 60 seconds.

2

AI reviews all critical clauses

Indemnification, IP, data rights, subject injury, confidentiality, and publication rights — reviewed against 847+ pharma precedents and your pre-approved fallback positions simultaneously.

3

Negotiate with memory

Accept, reject, or modify AI suggestions. Every decision is stored. Send counterparty redlines directly from TrialPact. Each negotiation makes the next one faster.

Ready to cut your CTA timeline?

Join the Waitlist
EARLY ACCESS

Join the founding cohort.

We're onboarding 50 founding teams with direct product team access and input on the roadmap. No commitment required.

This field is required.
This field is required.
This field is required.
Please select an option.
Please select an option.

By submitting, you agree to receive product updates from TrialPact. Unsubscribe anytime. We do not share your information.

SHAPE THE ROADMAP

Tell us what to build next.

We read every submission. Features with the most traction ship first. If you're a founding team member, your requests go to the top of the queue.

✓ We respond to every request within 5 business days
✓ High-vote features ship within 90 days
✓ Founding members get early access to requested features
This field is required.
This field is required.
Action completed.